Additionally, genetic predispositions influencing inflammation, such as variations in interleukin genes (e.g., IL‐6, IL‐1β), may affect the degree of erythema and scarring, leading to differing outcomes among patients receiving the same treatment [20]. The gene discussed is IL1B; the disease is Erythema.